Eye Recovery Pro (PH-e03)
Shenzhen Goodwind Technology Development Co., Ltd. · Decision date Aug 10, 2026
What did the FDA decide?
FDA records K261602 as a 510(k) premarket notification, with a decision dated Aug 10, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Aug 10, 2026
Regulatory record facts
- Identifier
- K261602
- Regulatory pathway
- 510(k) premarket notification
- Product code
- OHS
- Decision code
- SESE
- Decision date
- Aug 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light Based Over The Counter Wrinkle Reduction.
- Product code
- OHS
- FDA device class
- 2
FDA decision timeline
K261602 received
Application receipt date recorded by FDA.
K261602 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OHS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Guangdong Newdermo Biotech Co., Ltd. | 510(k) clearance | Nov 4, 2026 | FDA | |
| Shenzhen Bway Tech Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Shenzhen Xinlong Precision Plastic Mold Products Co., Ltd. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Shenzhen Accompany Technology Co., Ltd. | 510(k) clearance | Oct 19, 2026 | FDA | |
| Kam Yuen Plastic Products , Ltd. | 510(k) clearance | Aug 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Goodwind Technology Development Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K261602
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


